| |
The MEDINET Group is engaged in the cell processing and cell therapy product businesses. The company operates in two business segments: the cell processing business and the cellular medical products business. In addition to providing immuno-cell therapy total support services to medical institutions, the cell processing business offers a wide range of services to corporate clients. In addition, we are entrusted by universities, medical institutions, research institutes, etc. with cell processing for clinical use and the manufacture of cell processing materials for clinical trials, as well as with the production of cell processing materials for clinical trials. Monetize the regenerative and cellular medicine value chain, manage the operation of cell culture and processing facilities, and provide cell processing technicians and provide education systems. |